Toll-Like Receptor 2 Attenuates the Formation and Progression of Angiotensin II-Induced Abdominal Aortic Aneurysm in ApoE-/- Mice

Overview

Journal J Vasc Res

Specialty Cardiology & Vascular Diseases

Date 2024 Oct 28

PMID 39467520

Authors

Yali Zhang

Jessamyn Bagley

Ho-Jin Park

Xuehong Cao

Elena Maganto-Garcia

Andrew Lichtman

Debbie Beasley

Jonas B Galper

Affiliations

Soon will be listed here.

Abstract

Introduction: We demonstrated Toll-like receptor (TLR) 4 in the pathogenesis of angiotensin II (AngII)-mediated abdominal aortic aneurysm (AAA) formation. Here, we study TLR2 in the AAA formation.

Methods: Male ApoE-/- and ApoE-/-TLR2-/- mice were treated with AngII. Mice were injected with the TLR2 agonist Pam3CSK4. The incidence and severity of AAA were determined. MCP-1, MCP-5, RANTES, CXCL10, CCR5, and CXCR3 were analyzed. M1 and M2 macrophages in the aorta were detected by flow cytometry.

Results: These studies demonstrated an increase in AAA formation in TLR2-/- mice and a decrease by Pam3CSK4. Pam3CSK4 decreased the ratio of M1/M2 and the levels of RANTES, CXCL10, CCR5, and CXCR3. Furthermore, Pam3CSK4 treatment 1 week following AngII retarded the progression of AAA.

Conclusion: These data demonstrated a protective effect of TLR2 signaling on AAA in association with a decrease in the ratio of M1 to M2 macrophages and the expression of chemokines and their receptors. Furthermore, the treatment of Pam3CSK4 after AngII demonstrated a marked retardation of lesion progression. Given the fact that most AAA patients are detected late in the disease process, these findings suggest that TLR2 stimulation may play a therapeutic role in retarding disease progression.

References

Malle E, Sodin-Semrl S, Kovacevic A . Serum amyloid A: an acute-phase protein involved in tumour pathogenesis. Cell Mol Life Sci. 2008; 66(1):9-26. PMC: 4864400. DOI: 10.1007/s00018-008-8321-x. View

Suzaki Y, Hamada K, Nomi T, Ito T, Sho M, Kai Y . A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation. Eur Respir J. 2007; 31(4):783-9. DOI: 10.1183/09031936.00111507. View

Cowan Jr J, Dimick J, Henke P, Rectenwald J, Stanley J, Upchurch Jr G . Epidemiology of aortic aneurysm repair in the United States from 1993 to 2003. Ann N Y Acad Sci. 2006; 1085:1-10. DOI: 10.1196/annals.1383.030. View

Geissmann F, Manz M, Jung S, Sieweke M, Merad M, Ley K . Development of monocytes, macrophages, and dendritic cells. Science. 2010; 327(5966):656-61. PMC: 2887389. DOI: 10.1126/science.1178331. View

Iwasaki A, Medzhitov R . Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004; 5(10):987-95. DOI: 10.1038/ni1112. View

Galkina E, Kadl A, Sanders J, Varughese D, Sarembock I, Ley K . Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med. 2006; 203(5):1273-82. PMC: 2121208. DOI: 10.1084/jem.20052205. View

Horuluoglu B, Bayik D, Kayraklioglu N, Goguet E, Kaplan M, Klinman D . PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus. J Autoimmun. 2019; 99:24-32. PMC: 6462249. DOI: 10.1016/j.jaut.2019.01.004. View

Daugherty A, Cassis L . Mechanisms of abdominal aortic aneurysm formation. Curr Atheroscler Rep. 2002; 4(3):222-7. DOI: 10.1007/s11883-002-0023-5. View

Takami S, Minami M, Katayama T, Nagata I, Namura S, Satoh M . TAK-779, a nonpeptide CC chemokine receptor antagonist, protects the brain against focal cerebral ischemia in mice. J Cereb Blood Flow Metab. 2002; 22(7):780-4. DOI: 10.1097/00004647-200207000-00003. View

10.

Daugherty A, Manning M, Cassis L . Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000; 105(11):1605-12. PMC: 300846. DOI: 10.1172/JCI7818. View

11.

Ha T, Hua F, Liu X, Ma J, McMullen J, Shioi T . Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism. Cardiovasc Res. 2008; 78(3):546-53. DOI: 10.1093/cvr/cvn037. View

12.

Zhang Y, Naggar J, Welzig C, Beasley D, Moulton K, Park H . Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: possible role of ERK. Arterioscler Thromb Vasc Biol. 2009; 29(11):1764-71. PMC: 2771227. DOI: 10.1161/ATVBAHA.109.192609. View

13.

Tang D, Park H, Georgescu S, Sebti S, Hamilton A, Galper J . Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA. Life Sci. 2006; 79(15):1484-92. DOI: 10.1016/j.lfs.2006.04.019. View

14.

Daugherty A, Cassis L . Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2004; 24(3):429-34. DOI: 10.1161/01.ATV.0000118013.72016.ea. View

15.

Baba M, Nishimura O, Kanzaki N, Okamoto M, Sawada H, Iizawa Y . A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci U S A. 1999; 96(10):5698-703. PMC: 21923. DOI: 10.1073/pnas.96.10.5698. View

16.

Qin Z, Bagley J, Sukhova G, Baur W, Park H, Beasley D . Angiotensin II-induced TLR4 mediated abdominal aortic aneurysm in apolipoprotein E knockout mice is dependent on STAT3. J Mol Cell Cardiol. 2015; 87:160-70. DOI: 10.1016/j.yjmcc.2015.08.014. View

17.

Ortiz-Munoz G, Martin-Ventura J, Hernandez-Vargas P, Mallavia B, Lopez-Parra V, Lopez-Franco O . Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis. Arterioscler Thromb Vasc Biol. 2009; 29(4):525-31. DOI: 10.1161/ATVBAHA.108.173781. View

18.

Fukushima A, Yamaguchi T, Ishida W, Fukata K, Ueno H . TLR2 agonist ameliorates murine experimental allergic conjunctivitis by inducing CD4 positive T-cell apoptosis rather than by affecting the Th1/Th2 balance. Biochem Biophys Res Commun. 2005; 339(4):1048-55. DOI: 10.1016/j.bbrc.2005.11.114. View

19.

Patel M, Xu D, Kewin P, Choo-Kang B, McSharry C, Thomson N . TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J Immunol. 2005; 174(12):7558-63. DOI: 10.4049/jimmunol.174.12.7558. View

20.

Movahedi K, Laoui D, Gysemans C, Baeten M, Stange G, Van den Bossche J . Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 2010; 70(14):5728-39. DOI: 10.1158/0008-5472.CAN-09-4672. View